-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Nurix Therapeutics, Inc. quarterly/annual Income Tax Expense (Benefit) history and change rate from Q3 2019 to Q3 2025.
- Nurix Therapeutics, Inc. Income Tax Expense (Benefit) for the quarter ending 31 Aug 2025 was $0.000, a 100% decline year-over-year.
- Nurix Therapeutics, Inc. Income Tax Expense (Benefit) for the twelve months ending 31 Aug 2025 was $768K, a 193% increase year-over-year.
- Nurix Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2024 was $270K.
- Nurix Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2023 was $0.000.
- Nurix Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2022 was $0.000, a 100% decline from 2021.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Change (%)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Change (%)